NVCR
NovoCure LimitedstockNASDAQ
Market OpenNov 19, 2026 3:38:29 PM EST
10.70USD-0.280%(-0.03)969,531
NVCR Financials
In Q3 FY 2026 (ended ), NovoCure Limited (NVCR) reported revenue of $193.4M, net income of −$10.44M, operating cash flow of $22.67M, and assets of $828.71M (filed ).
Loading financial statements…
